Search

Your search keyword '"Furuichi, Kengo"' showing total 9 results
Start Over Author "Furuichi, Kengo" Journal plos one
9 results on '"Furuichi, Kengo"'

2. Evaluation of renal oxygen saturation using photoacoustic imaging for the early prediction of chronic renal function in a model of ischemia-induced acute kidney injury

Author

Okumura, Kenichiro, primary, Matsumoto, Junichi, additional, Iwata, Yasunori, additional, Yoshida, Kotaro, additional, Yoneda, Norihide, additional, Ogi, Takahiro, additional, Kitao, Azusa, additional, Kozaka, Kazuto, additional, Koda, Wataru, additional, Kobayashi, Satoshi, additional, Inoue, Dai, additional, Sakai, Norihiko, additional, Furuichi, Kengo, additional, Wada, Takashi, additional, and Gabata, Toshifumi, additional

Published
2018
Full Text
View/download PDF

3. A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy

Author

Hoshino, Junichi, primary, Furuichi, Kengo, additional, Yamanouchi, Masayuki, additional, Mise, Koki, additional, Sekine, Akinari, additional, Kawada, Masahiro, additional, Sumida, Keiichi, additional, Hiramatsu, Rikako, additional, Hasegawa, Eiko, additional, Hayami, Noriko, additional, Suwabe, Tatsuya, additional, Sawa, Naoki, additional, Hara, Shigeko, additional, Fujii, Takeshi, additional, Ohashi, Kenichi, additional, Kitagawa, Kiyoki, additional, Toyama, Tadashi, additional, Shimizu, Miho, additional, Takaichi, Kenmei, additional, Ubara, Yoshifumi, additional, and Wada, Takashi, additional

Published
2018
Full Text
View/download PDF

4. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy

Author

Yamanouchi, Masayuki, primary, Hoshino, Junichi, additional, Ubara, Yoshifumi, additional, Takaichi, Kenmei, additional, Kinowaki, Keiichi, additional, Fujii, Takeshi, additional, Ohashi, Kenichi, additional, Mise, Koki, additional, Toyama, Tadashi, additional, Hara, Akinori, additional, Kitagawa, Kiyoki, additional, Shimizu, Miho, additional, Furuichi, Kengo, additional, and Wada, Takashi, additional

Published
2018
Full Text
View/download PDF

5. Association of PAX2 and Other Gene Mutations with the Clinical Manifestations of Renal Coloboma Syndrome

Author

Okumura, Toshiya, primary, Furuichi, Kengo, additional, Higashide, Tomomi, additional, Sakurai, Mayumi, additional, Hashimoto, Shin-ichi, additional, Shinozaki, Yasuyuki, additional, Hara, Akinori, additional, Iwata, Yasunori, additional, Sakai, Norihiko, additional, Sugiyama, Kazuhisa, additional, Kaneko, Shuichi, additional, and Wada, Takashi, additional

Published
2015
Full Text
View/download PDF

6. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.

Author

Oshima, Megumi, Toyama, Tadashi, Haneda, Masakazu, Furuichi, Kengo, Babazono, Tetsuya, Yokoyama, Hiroki, Iseki, Kunitoshi, Araki, Shinichi, Ninomiya, Toshiharu, Hara, Shigeko, Suzuki, Yoshiki, Iwano, Masayuki, Kusano, Eiji, Moriya, Tatsumi, Satoh, Hiroaki, Nakamura, Hiroyuki, Shimizu, Miho, Hara, Akinori, Makino, Hirofumi, and Wada, Takashi

Subjects
GLOMERULAR filtration rate, KIDNEY function tests, KIDNEY disease risk factors, TYPE 2 diabetes complications, PEOPLE with diabetes
Abstract

Background: According to studies by the National Kidney Foundation and Food and Drug Administration, 30% and 40% declines in estimated glomerular filtration rate (eGFR) could be used as surrogate endpoints of end-stage renal disease (ESRD). However, the benefits of using these endpoints in diabetic patients remain unclear. Methods: This cohort study comprised Japanese patients with type 2 diabetes; those with repeated serum creatinine measurements during a baseline period of 2 years (n = 1868) or 3 years (n = 2001) were enrolled. Subsequent risks of ESRD following eGFR declines were assessed. Results: In the 2-year baseline analysis, the cumulative prevalence of −20%, −30%, −40%, and −53% changes in eGFR were 23.9%, 11.1%, 6.8%, and 3.7%, respectively. There were 133 cases (7.1%) of subsequent ESRD during a median follow-up period of 6.5 years. In the 3-year baseline analysis, the corresponding proportions were 28.1%, 14.0%, 7.7%, and 3.9%, respectively, with 110 participants (5.5%) reaching ESRD during a median follow-up period of 5.5 years. The adjusted hazard ratios of subsequent ESRD following −53%, −40%, −30%, and −20% changes in eGFR during the 2-year baseline period were 22.9 (11.1–47.3), 12.8 (6.9–23.7), 8.2 (4.3–15.5), and 3.9 (2.2–7.0), respectively when compared with the no changes in eGFR. In the 3-year baseline analysis, the corresponding risks were 29.7 (10.8–81.9), 18.4 (7.6–44.7), 12.8 (5.2–32.2), and 5.4 (2.3–12.8), respectively. In the subgroup analysis, similar trends were observed in patients with macroalbuminuria at baseline. Conclusions: Declines in eGFR were strongly associated with subsequent risk of ESRD in Japanese type 2 diabetic patients. In addition to 30% and 40% declines, a 20% decline in eGFR over 2 years could be considered as a candidate surrogate endpoint of ESRD in diabetic kidney disease. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

7. Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney Function

Author

Toyama, Tadashi, primary, Furuichi, Kengo, additional, Shimizu, Miho, additional, Hara, Akinori, additional, Iwata, Yasunori, additional, Sakai, Norihiko, additional, Perkovic, Vlado, additional, Kobayashi, Makoto, additional, Mano, Toshiki, additional, Kaneko, Shuichi, additional, and Wada, Takashi, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results